Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
about
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agentsOptimizing antimicrobial therapy in critically ill patientsComparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysisApplication of microdialysis for pharmacokinetic-pharmacodynamic modelling.A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.Disposition kinetics and urinary excretion of cefpirome after intravenous injection in buffalo calves.Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats.Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.The ability of fluconazole to penetrate into ventilated, healthy and inflamed lung tissue in a model of severe sepsis in rats.Gewebepenetration von Antibiotika
P2860
Q26827380-94C49970-A410-43AF-A130-6181E5FF5CAEQ26999905-F00BFE87-832B-4E9F-9BDA-1487A0BDC3D8Q35005118-35810649-F079-477D-B3C1-4CB6635169E6Q35908084-7E389C36-B978-4D7E-9EEB-579CDBF3EDB1Q37149078-28B65323-00B4-4A41-99CE-BB29A2F1E7DFQ37247602-2AE731D5-A179-40B1-8075-403028BAA3E6Q38089788-752F5503-E245-47B9-A1F5-C915EFEEFB87Q38223948-631D98F7-6D98-4D2D-9300-7E51AC6DF091Q39048274-160FB468-B0E1-4E2B-B1B1-C66B15AF5C28Q40639279-A48D53CF-4D95-4050-B346-FF5F54DCDB64Q41572033-8FBE36CF-C019-4E08-A935-078F7B8BF4FEQ41692446-96AC7960-9A10-49B2-9021-D4ACA1E477DBQ47656109-7049AE01-A581-464C-A35D-E5DB03405F15Q54363111-A2908C58-6542-4864-AED3-5017E6918D82Q56777192-2219BB9B-6978-4DA3-B81C-2C2BF4E9CBB9
P2860
Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@ast
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@en
type
label
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@ast
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@en
prefLabel
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@ast
Pharmacokinetics and pharmacod ...... ose tissue of septic patients.
@en
P2093
P2860
P1476
Pharmacokinetics and pharmacod ...... pose tissue of septic patients
@en
P2093
Apostolos Georgopoulos
Bernhard X Mayer-Helm
Christian Joukhadar
Claudia Marsik
Georg Delle-Karth
Ilka Steiner
Markus Müller
Robert Sauermann
P2860
P304
P356
10.1128/AAC.49.2.650-655.2005
P407
P577
2005-02-01T00:00:00Z